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a r t i c l e s SNAREs are at the core of the vesicle-organelle and organelleorganelle membrane fusion machinery as a consequence of their ability to provide much of the mechanical energy and specificity to these events. They are small membrane proteins that contain at least one 60-residue SNARE motif. Four SNARE motifs come together to form a four-helix bundle called the trans-SNARE complex. One SNARE (an R-SNARE, previously called a vesicle SNARE or v-SNARE) is on one of the membranes to be fused, and the other SNAREs (Q-SNAREs, previously called target SNAREs or t-SNAREs) are on the other. The 'zippering up' of the SNARE motifs pulls the two membranes into sufficiently close apposition to allow fusion to proceed (reviewed in refs. 1, 2) . Only certain combinations of the 38 mammalian SNAREs are able to form fusogenic trans-SNARE complexes, and this ability has a major role in conferring specificity to the fusion process 3, 4 . Both the fusogenic activity of SNAREs and their localization to specific intracellular membranes must be carefully controlled if the vesicle transport system is to function correctly. The subcellular distribution of the SNAREs is determined by incorporation into or exclusion from the various types of route-specific transport vesicles and tubules within the cell.
In most SNAREs, the SNARE motif is preceded by either a short unstructured peptide of 10-30 residues or a folded domain of 100-150 residues 1 . The syntaxins and Vti1 (VPS10 tail interactor 1) SNAREs have three-helix Habc domains, which, in some cases, bind back onto the SNARE's own SNARE motif and so can inhibit their ability to participate in SNARE complex formation (reviewed in ref. 5 ). In the Qa-SNAREs, regions of the Habc domain interact with proteins of the Munc18 family to regulate Qa-SNARE incorporation into SNARE complexes, with both inhibitory and activating roles having been proposed [6] [7] [8] [9] .
In mammalian cells, the major post-Golgi R-SNAREs are the VAMPs, of which only VAMP7 has a folded N-terminal region: a 120-residue mixed α and β longin domain that is also present in the R-SNAREs Sec22b and Ykt6 (ref. 10) . VAMP7 is highly conserved across eukaryotes, is ubiquitously expressed and has been reported to be involved in a variety of membrane trafficking events. VAMP7 is also important for heterotypic fusion events both between terminal endocytic compartments (late endosomes and lysosomes) by complexing with syntaxin7, syntaxin8 and vti1b 11 and between these organelles and other cellular membranes, including autophagosomes 12, 13 and, by complexing with syntaxin3 or syntaxin4 and SNAP23, the limiting membrane of the cell 14 . The latter complex allows VAMP7 to have a role in wound healing 14, 15 , metastasis through secretion of the endolysosomal membrane type 1 matrix metalloproteinase protein 16 and the expansion of the plasma membrane during mitosis 17 . VAMP7 also has an important role in secretion in specialized cells (reviewed in ref. 15 ), neurite outgrowth 18 and dendrite formation in melanocytes 19 and has been implicated in more generalized secretion to the plasma membrane from the trans-Golgi network 15 . Because of its involvement in such a diverse set of important membrane fusion events, it is logical that both the organelle-localization and fusogenic activity of VAMP7 should be tightly controlled.
To identify binding partners for VAMP7 that could regulate its localization and ability to form fusogenic SNARE complexes, we 20 and others [21] [22] [23] used yeast two-hybrid screening (Y2H) for both the entire cytosolic region and the isolated N-terminal longin domain a r t i c l e s of VAMP7. Screening with the longin domain identified two vesicle-coat components, the heterotetrameric AP3 adaptor complex δ-adaptin subunit and Hrb, a clathrin adaptor and member of the ArfGAP family, both of which direct the trafficking of VAMP7 along the endocytic pathway 20, [22] [23] [24] . Here we demonstrate that the widely expressed, multidomain protein Varp (Vps9 and ankyrin repeat-containing protein), which is an endosomal Rab21 guanine nucleotide exchange factor (GEF) 25 and effector for Rab32 and Rab38 (refs. 26,27) , is a binding partner for the full cytosolic portion of VAMP7 but not for the isolated longin domain nor the SNARE motif alone. We have solved the structure of the complex between the VAMP7 cytosolic domain and an ankyrin repeatcontaining portion of Varp. In the structure, the SNARE motif of VAMP7 binds back onto its longin domain and is trapped there by Varp. This results in a rate of SNARE complex formation for fulllength VAMP7 in the presence of Varp that is 65 times slower than the rate of complex formation when the Varp-interacting longin domain is removed from VAMP7, meaning that Varp elicits a kinetic inhibitory effect. Potential roles of this inhibition in vivo are discussed in the light of the other functions of Varp.
RESULTS

Varp binds only to the whole cytosolic domain of VAMP7
Our parallel Y2H screens of complementary DNA libraries using the VAMP7 longin domain (VAMP7LD) and the full VAMP7 cytosolic domain (VAMP7CD) gave completely nonoverlapping results. Screening with the longin domain resulted in 37 identifications of δ-adaptin and 1 identification of Hrb as binding partners. Our screen with the full-length cytosolic domain of VAMP7 showed no interaction with Hrb or δ-adaptin but did show interaction with SNAP29 (1 identification) and Varp (11 identifications) as binding partners (Supplementary Fig. 1 ). These data are in broad agreement with previously published studies [21] [22] [23] . We cloned the open reading frame of the full-length human Varp gene from the IMAGE clone IMAGE:6067580 and confirmed the interaction with VAMP7 by Y2H ( Supplementary  Fig. 1 (20 min) . N, proteolytic products of Varp with an N terminus identical to that of the full-length protein; the asterisk indicates the C-terminal chymotryptic fragment of Varp (residues 653-1050) with an intact C-terminal His 10 tag. Western blotting of the SDS-PAGE (right) showed that, of the proteolytic fragments produced, the only detectable interaction was between the C-terminal chymotryptic fragment of Varp (residues 653-1050) and GST-VAMP7CD. Chym, chymotryptic digestion products; tryp, tryptic digestion products. (c) Panel order as in a. His 10 -tagged residues 653-1050, 658-921, but not 718-921, of Varp can bind to GST-VAMP7CD, whereas no Varp constructs bind to GST-VAMP7LD. (d) Domain organization of human Varp (left) and mouse VAMP7 (right) as indicated by pfam 30 and described previously 25 . The color scheme used is replicated in all subsequent figures. A summary of the mapping of the interaction determined using the constructs indicated is shown. (e) Panel order as in a. Varp 658-921 -His 6 is able to bind GST-VAMP7CD but not the GST-VAMP7-SNARE motif or GST-VAMP7LD. (f) Panel order as in a. Varp 658-921 -His 6 cannot bind to the GST-tagged full cytosolic domains of the mammalian longin domain-containing SNAREs Sec22b (GST-Sec22bCD) and Ykt6 (GST-Ykt6CD). (g) Panel order as in a. Truncating GST-VAMP7 before residue 160 abolishes binding to Varp 658-921 -His 6 . npg a r t i c l e s endogenous Varp from MNT-1 cells (Supplementary Fig. 1 ) and Varp expressed in a C-terminally His 10 -tagged form in Escherichia coli ( Fig. 1) . However, in both Y2H and the GST pulldown experiments, only the full-length cytosolic portion of VAMP7, but neither the isolated longin domain nor the isolated SNARE motif ( Fig. 1) , interacted with Varp. This is consistent with our subsequent structural work but not with previously published data 21 .
Mapping the VAMP7-interacting domain of Varp
We then used domain analysis and structure prediction 28, 29 in combination with N-terminal sequencing of limited tryptic and chymotryptic proteolytic digests of full-length Varp to identify stable domains of Varp (Fig. 1) . The smallest of the designed stable domains that still bound strongly to VAMP7 consisted of residues 658-921 of Varp, which includes the second predicted set of four adjacent ankyrin repeats 30 and part of the linker between these and the first predicted set of ankyrin repeats. This domain also contains the smallest portion of Varp 641-707 that is common to all VAMP7interacting clones identified in another study 21 and the smallest region (residues 671-731) found in a single interacting clone in our own Y2H screen ( Supplementary Fig. 1 ). As in the full-length protein, residues 658-921 of Varp bound only to full-length VAMP7 and not the isolated SNARE motif or the longin domain and were also unable to bind the full-length cytosolic portions of the other longin domain-containing SNAREs Ykt6 and Sec22 ( Fig. 1 and Supplementary Figs. 1 and 2) .
Residues 658-921 of Varp showed robust binding to the VAMP7 full-length cytosolic domain (residues 1-188). We measured the dissociation constant (K d ) and the stoichiometry of the interaction by isothermal titration calorimetry (ITC) as 2.3 ± 0.6 µM (mean ± s.d.) and 1:1, respectively, the latter of which we confirmed by gel filtration (Supplementary Fig. 2e ). ITC gave a similar K d for full-length Varp binding to VAMP7 (K d ~3 µM; Supplementary  Fig. 2) , indicating that no additional VAMP7 binding sites were present. In addition, residues 1-650 of Varp showed no binding to VAMP7 ( Supplementary Fig. 2) , and we did not identify any Varp clones in our Y2H screen that did not contain residues 671-731 ( Supplementary Fig. 1 ). Using C-terminal truncations of VAMP7, we also found that only residues 1-160 (containing the longin domain and the N-terminal portion of the SNARE motif) were necessary for binding of VAMP7 to Varp ( Fig. 1) .
Varp and VAMP7 colocalize in the endocytic pathway
In the absence of an antibody that detects endogenous Varp in cells, we expressed Varp with a hemagglutinin (HA) tag appended at its C terminus (Varp-HA) in NRK cells and showed good, although not complete, colocalization with endogenous VAMP7 and also with Rab7, a marker of late endosomes, using immunofluorescence microscopy ( Fig. 2) . Varp-HA also partially colocalized with lgp110 (also known as LAMP2), a marker of terminal endocytic compartments, but localized poorly with the trans-Golgi network (TGN) marker TGN38 (Supplementary Fig. 3 ). We were also able to detect faint Varp-HA staining at the cell periphery. Immunogold electron microscopy of NRK cells expressing Varp-HA showed the presence of Varp on organelles with the characteristics of endosomes, vesicular tubular elements, lysosomes and the plasma membrane ( Fig. 2 and Supplementary Fig. 3 ). This localization pattern was also consistent with sites at which VAMP7 has previously been shown to localize and suggested to function 23, 31 . The localization of Varp is consistent with it being an effector of the two highly similar Rabs Rab32 and Rab38 (67% sequence identity 26, 27 ), which, together with Rab7, Rab7L1, Rab29 and Rab23, are classified as the late endocytic group III Rabs 32 . Rab32 is expressed at low levels in a wide variety of cell types [33] [34] [35] , including the NRK cells used in this study Supplementary Fig. 3 ), and has previously been detected on late endocytic pathway organelles and, along with Rab38, on melanosomes 26, [36] [37] [38] . Thus, the recently reported physiological roles of the interaction of Varp with VAMP7, including the Rab32-and Rab38dependent Tyrp1 trafficking in melanocytes 19 , are consistent with this localization of Varp. We also found that a 75% depletion of Varp 24 . The VAMP7-SNARE motif (green), the Hrb peptide (gold) and the δ-adaptin peptide (cyan) all bind to the same groove of VAMP7LD (purple). Hydrophobic residues that slot into the hydrophobic groove of VAMP7LD are shown. (e) Structure-based alignment of the three VAMP7LD-binding sequences showing that they share a pattern of hydrophobic side chains (yellow shading), but the key residues are separated by distinct sequences. (f) Ribbon representations of the three complexes in e superimposed on the basis of the longin domains. npg a r t i c l e s by short interfering RNA (siRNA) treatment in NRK cells showed no readily detectable alteration in the trafficking of VAMP7 and only a subtle increase in the steady-state colocalization of VAMP7 with a terminal endocytic compartment marker ( Supplementary Fig. 3) , which is consistent with an increase in the amount of fusion between the late and terminal endocytic compartments.
The structure of the Varp-VAMP7 complex
The robust interaction between the stable domain consisting of residues 658-921 of Varp and the VAMP7 cytosolic domain (K d ~2 µM) allowed us to purify a complex of the two individually expressed proteins by gel filtration (Supplementary Fig. 4) . We crystallized the complex between the two proteins and solved its structure by multiple isomorphous replacement using mercury derivatives ( Table 1 ). The structure of VAMP7LD was as expected from previous studies, but we found that Varp 658-921 forms a stack of six ankyrin repeats rather than the four that were predicted ( Fig. 3 and Supplementary Fig. 4 ) 30 . The first ankyrin repeat, although separated from the next five repeats by a disordered region (residues 694-729) for which we found no electron density, contacts the second ankyrin repeat through an extensive and tightly packed hydrophobic interface. The VAMP7 binds on top of the ankyrin repeat stack, binding almost exclusively to the first repeat, and this represents a new mode of ligand binding by ankyrin repeats ( Fig. 3  and Supplementary Fig. 5 ).
In the Varp-VAMP7 complex, the final 24 residues of the VAMP7 cytosolic region (164-188), which are dispensable for binding to Varp ( Fig. 1 and Supplementary Fig. 6 ), are not visible in the structure.
Similarly, residues 121-128, which link the longin domain to the SNARE motif ( Supplementary Fig. 6 ), also have no electron density. The complex structure shows that, when bound to Varp, VAMP7 adopts a closed conformation whose existence has been previously suggested for the isolated protein free in solution 23, 39 . In this closed state, an ordered part of the SNARE motif (residues 129-163) binds back in an extended conformation in a groove stretching halfway around globular VAMP7LD (Fig. 3) . The interaction between the longin domain and the SNARE motif is mediated largely by the hydrophobic side chains ( Figs. 3 and 4) , burying ~2,300 Å 2 of accessible surface area (calculated with PISA 40 ), which explains the stability of this interaction in solution. A subset of these longin domain-interface residues are protected in NMR experiments, confirming that the intramolecular 'bound-back' conformation of VAMP7 in the complex structure presented here is preformed in solution and trapped by Varp 39 . Comparison with the structures of VAMP7-Hrb 20 and VAMP7-δ-adaptin 24 shows a similar binding mode in the same groove on VAMP7LD for fragments of Hrb, δ-adaptin and the VAMP7-SNARE motif, with the same longin domain residues being important to all three interactions ( Fig. 3) . Thus, the interactions of VAMP7LD with Hrb or δ-adaptin and the SNARE motif are mutually exclusive. There is, however, little homology between the three longin domain ligands: their key residues are differently spaced, and, therefore, we could not predict their mechanisms of binding without detailed structural information. The major difference between the three interactions is that the interaction between VAMP7LD and its SNARE motif is intramolecular and the other two interactions are intermolecular; a r t i c l e s hence the intramolecular interaction will predominate in solution. The SNARE motif residues Ile139 and Ile144 are key to its binding back onto its own longin domain, and this explains why the triple mutation of I139S, M140S and I144S disrupts the interaction between the VAMP7-SNARE motif and its longin domain, leaving its longin domain free to bind Hrb 20 .
Effect of mutating residues in the Varp-VAMP7 interface
The longin domain and the SNARE motif make approximately equal contributions to VAMP7 binding to Varp (Figs. 3-5 ). Because the Varp binding site on VAMP7 can only be formed when the extended SNARE motif passes through the groove on the longin domain, the complete cytosolic domain of VAMP7 is required for Varp binding, and neither the longin domain nor the SNARE motif on their own are sufficient for the interaction (Fig. 1) . Thus, our structural data are entirely consistent with our interaction data determined by both Y2H and GST pulldowns.
The interface buries a total of 1,200 Å 2 of solvent-accessible surface area, a figure that, although not inconsistent with the K d of ~2 µM for the interaction, is on the low side of what could be expected for this K d value. This may be explained by the network of charged hydrogen bonds centered on Arg72 of the longin domain, which is 90% buried, with most of the hydrogen bonds consequently protected from solvent. ( Fig. 5 and Supplementary Fig. 6 ).
Regions of contact involve contributions from all three components of the complex (Fig. 5) . Using ITC experiments, we demonstrated that mutations in residues that are crucial to the interaction between all three components, M684D Y687S and D679A D681A in Varp and R72A and D69A E71F S73D in VAMP7, abolished complex formation ( Fig. 5) but did not affect protein folding, as judged by behavior during purification and circular dichroism (data not shown). The effects of these mutations confirm that the complex identified in the crystal structure is the same as that in solution. Most of the residues in VAMP7 that are involved in Varp binding are not conserved in the other longin domain-containing SNAREs Sec22 and Ykt6 (Supplementary Fig. 6 ), which explains why these SNAREs have no binding to Varp (Fig. 1f) .
Varp inhibits the ability of VAMP7 to form SNARE complexes
The intermolecular Hrb and AP3 δ-adaptin interactions with VAMP7 direct the trafficking of inactive cis-SNARE complexes containing VAMP7, suggesting that the intramolecular interaction of Varp with uncomplexed VAMP7 has a different cellular role. The complex structure indicates that Varp traps a closed conformation of VAMP7 in which the SNARE motif is unavailable for cognate trans-SNARE complex formation. In VAMP2, VAMP3 and VAMP8, a trigger-site sequence initiates SNARE complex formation 41 . The equivalent trigger sequence of VAMP7, residues 136-142 (LKGIMVR), is sandwiched in the VAMP7-Varp interface, with the crucial isoleucine and methionine residues buried in the center of the interface (Fig. 6) .
To test the hypothesis that Varp binding inhibits the ability of VAMP7 to form SNARE complexes, we analyzed the formation of the syntaxin7-syntaxin8-Vti1b-VAMP7 SDS-stable SNARE complex (Supplementary Fig. 7) as a function of Varp 658-921 -His 6 concentration. We found that the extent of SNARE complex formation is inversely correlated with the concentration of Varp 658-921 -His 6 present in the reaction, whereas the VAMP7 nonbinding mutant of Varp 658-921 -His 6 (M684D Y687S) did not inhibit SNARE complex formation (Fig. 6) . In a related set of experiments, we analyzed the time dependence of SNARE complex formation on the full-length cytosolic portion of GST-VAMP7 and on the GST-VAMP7-SNARE motif (which is missing the putative inhibitory longin domain) in the presence of wild-type and M684D Y687S mutant Varp 658-921 -His 6 and in the absence of Varp 658-921 -His 6 ( Fig. 6 and Supplementary Figs. 7 and 8) . In assays with the full GST-VAMP7 cytosolic domain, wild-type Varp 658-921 -His 6 , but not the M684D Y687S mutant, reduced the rate of SNARE complex formation to about 30% of the rate when no Varp was present (notably, however, after 24 h, the level of SNARE complex attained in the presence of wild-type Varp 658-921 -His 6 was still only 80% of that achieved when the M684D Y687S VAMP7 nonbinding mutant was present). The SNARE complex formation rates were the highest when using the GST-VAMP7-SNARE motif ( Fig. 6d and Supplementary  Fig. 8) , thus confirming the proposed inhibitory role of the longin domain 23 . In this case, the presence of wild-type or M684D Y687S mutant Varp had no observable influence on complex formation, which again is in line with our observations that the binding of Varp to VAMP7 occurs only to the full-length VAMP7 cytosolic domain. Thus, the presence of the longin domain on VAMP7 and the addition of Varp together resulted in a rate of SNARE complex formation that was 60-70 times slower than that with the isolated VAMP7-SNARE motif (in other words, only 1.5% of the rate seen with the isolated motif), demonstrating that, at least in vitro, this two-component system functions as an effective kinetic inhibitory system for VAMP7-mediated SNARE complex formation.
Varp does not inhibit VAMP8's ability to form SNARE complexes
VAMP8, which is also found on compartments of the endocytic pathway 11, 42, 43 , is closely related to VAMP7 (43% sequence identity and 68% similarity) in their SNARE motifs, and both can form complexes with the same Q-SNAREs (syntaxin7, syntaxin8 and Vti1b) 11, [42] [43] [44] , but VAMP8 has no longin domain. We therefore investigated the rate of complex formation with syntaxin7 and syntaxin8 (SNARE motifs only) on GST-Vti1b for VAMP7 and thioredoxin (Trx)-VAMP8 and tested whether they were sensitive to the presence of Varp 658-921 -His 6 . The rate of SNARE complex formation for VAMP8 was faster than for VAMP7, with around six times more SNARE complex formed with VAMP8 than with full-length VAMP7 after 2.5 h, and was similar to the rate with the isolated VAMP7-SNARE motif (Figs. 6 and 7) . Again, as with the VAMP7-SNARE motif only (Fig. 6) , the presence of Varp 658-921 -His 6 at either an equimolar or a ten-fold excess of the amount of VAMP caused no obvious reduction in the amount of VAMP8 incorporated into SNARE complexes but markedly reduced the amount of VAMP7 that incorporated. In fact, to achieve approximately equal amounts of VAMP7 and Trx-VAMP8 incorporation into SNARE complexes when they were both present in the same reaction and when Varp was absent, we needed to use ten times as much VAMP7 as Trx-VAMP8. Under these conditions, the presence of Varp 658-921 -His 6 at an equimolar and a ten-fold excess of the amount of VAMP caused a 74% and a 95% reduction, respectively, in the amount of VAMP7 incorporated into SNARE complexes compared to the reaction without Varp, whereas the amount of Trx-VAMP8 incorporated in these conditions increased by 20% and 27%, respectively.
Varp binds simultaneously to VAMP7 and Rab32 or Rab38
It has been demonstrated that residues 378-717 of Varp, which are predicted to contain another set of ankyrin repeats, interact with the GTP-bound form of the closely related endosomal Rabs Rab32 and Rab38 (ref. 27 ). Because avidity effects through a single protein molecule binding multiple ligands on the same membrane can greatly increase the apparent affinity of a protein for a membrane 45, 46 , we investigated whether Varp could bind to both VAMP7 and Rab38-GTP or Rab32-GTP at the same time. We only detected VAMP7CD in pulldowns on GST-Rab38-GTP Q69L in the presence of Varp 451-921 -His 6 (Fig. 7c) , which contains both the VAMP7 and the Rab binding sites. We obtained identical results using Rab32 instead npg a r t i c l e s of Rab38, and neither Rab was able to bind directly to VAMP7 (data not shown). These data therefore establish that Varp can bind simultaneously to both VAMP7 and Rab32-GTP or Rab38-GTP.
DISCUSSION
If VAMP7-mediated fusion events of various organelles with endolysosomes (reviewed in refs. 47,48) took place at the wrong time and/or place, there would be serious consequences for the cell, with inappropriate luminal content digestion occurring. It therefore seems logical that VAMP7-mediated fusion events should be tightly and accurately controlled in both a spatial and temporal manner, and that inappropriate fusogenic behavior of VAMP7 must be effectively inhibited. This regulation must, however, occur in the context of low-nanomolar K d values for adding the R-SNARE to a preformed Q-SNARE complex 49 .
In this study, we show how the folded longin domain of VAMP7 binds back onto the unstructured trigger sequence of its own SNARE motif, thus inhibiting the SNARE motif from participating in SNARE complex formation, and how this intramolecular interaction can be stabilized by the subsequent binding of Varp. The binding site for Varp on VAMP7 is only created when the longin domain and the SNARE motif bind to each other, which explains why binding to Varp only occurs with the full-length cytosolic domain of VAMP7. The result of this two-component inhibitory system (longin domain and Varp) is that the rate of SNARE complex formation is 60-70 times slower than that when a VAMP7 form lacking its longin domain is present 23 (Fig. 6) . However, under in vitro experimental conditions in which only VAMP7, its cognate Q-SNAREs and Varp are present in solution, Varp cannot prevent the eventual incorporation of VAMP7 into SNARE complexes: that is, thermodynamically, Varp cannot in the long term compete with complete SNARE complex formation and exerts only a kinetic inhibitory effect. This means that even when working in concert, the Varp-VAMP7 interaction (K d of ~2 µM) plus the interaction of the longin domain and the VAMP7-SNARE motif must be weaker than the low-nanomolar K d value of SNARE complex formation 49 . The effective K d for the intramolecular VAMP7 interaction is difficult to determine, but an upper limit to the effective K d for intact VAMP7 can be estimated from the K d of 10 µM for the interaction of the longin domain with Hrb that does not compete with the intramolecular binding between the VAMP7-SNARE motif and its longin domain 20 .
In vivo, the capacity of Varp to inhibit the participation of VAMP7 in SNARE complex formation and, consequently, inhibit VAMP7dependent fusion events can be enhanced over its ability to do so in vitro by an increase in its effective local concentration. This may be achieved through coincidence detection by the simultaneous binding of Varp to VAMP7 and other factors that are present on the same membrane as VAMP7 or on a membrane to which the VAMP7containing organelle or vesicle has been tightly tethered, such as GTPbound Rab32 or Rab38 (Fig. 8) . Similar to Varp, Rab32 is present on late endocytic compartments, as well as early and late stage autophagosomes, and both Rab32 and VAMP7 have been shown to be involved in autophagy 13, 36, 37 . That Rab32 is involved in the membrane fusion of endocytic compartments with endolysosomes is indicated by the observation that increased expression of the Rab32 GTPase-activating protein (GAP) RUTBC1 leads to an increase in mannose 6-phosphate receptor turnover in terminal endocytic compartments instead of the mannose 6-phosphate being recycled back from endosomes to the TGN 33, 50 . This can be explained by the GAP reducing the amount of Rab32-GTP, thus causing a reduction in the binding of Rab32 to Varp. This would in turn lead to a reduction in the concentration of Varp on late endocytic compartment membranes and therefore reduce the inhibition by Varp of the fusogenic ability of VAMP7, which is involved in the fusion of endosomes and autophagosomes with lysosomes [11] [12] [13] .
Rab32, its close homolog Rab38 and Varp are all enriched in cell types containing lysosome-related organelles such as platelets 51 and, especially, melanocytes, where they show good colocalization with VAMP7 (ref. 38 ). This probably reflects the importance of preventing Although the interactions of Varp with Rab38-GTP or Rab32-GTP have K d values of 2-5 µM ( Fig. 7 and data not shown), it has so far been technically impossible to measure the degree to which Rab38 or Rab32 immobilized on a membrane enhances the binding of Varp to VAMP7 embedded in the same membrane. Measurements of similar low micromolar-K d avidity-driven interaction systems with liposome-based surface plasmon resonance 45, 46 have suggested that the increase in binding from co-recognizing Rab32-GTP or Rab38-GTP and VAMP7 on the same membrane would be between 10-and 50-fold. A logical extension of an increased inhibitory effect on SNARE complex formation involving VAMP7 by Varp caused by simultaneous Rab32 and Rab38 binding is that in vivo it could be subsequently negated by GTP hydrolysis on Rab32 and Rab38 (as indicated in ref. 33) , thereby allowing spatial and/or temporal regulation of the inhibitory role of Varp on VAMP7. Indeed, such weakening would release free, fusogenically competent VAMP7, which could then drive membrane fusion events. That Varp can therefore ultimately have a role in driving VAMP7-mediated membrane fusion events at the correct time and place is supported by the recent demonstration that the VAMP7-Varp interaction is important for dendrite formation in melanocytes 19 . In addition, given the large size of Varp and the presence of multiple protein-protein interaction domains within it (Fig. 1) , other binding partners for Varp may exist that could function analogously to Rab32 and Rab38 in providing additional factors to recruit Varp to other VAMP7-containing membranes.
In vivo, both VAMP7 and VAMP8 are found throughout the endocytic pathway 11, 42, 43 . VAMP7 has been proposed to be involved in fusion events later in the pathway to the degradative endolysosome 11, 31, 47 , whereas VAMP8 is believed to be involved in the fusion of early endosomes and endosomal carriers with later endocytic compartments to deliver cargo and for endosome remodeling 11, 42, 43 . VAMP8, because it has no longin domain and consequently a high rate of SNARE complex formation that is insensitive to the presence of Varp, resembles a version of VAMP7 from which the longin domain has been deleted. Therefore, the kinetic inhibition by Varp of the participation of VAMP7 (but not VAMP8) in SNARE complex formation on endosomes would favor VAMP8-driven maturation of endosomes, where they acquire luminal contents. A combination of factors, including depletion of the pool of free VAMP8 and reducing the inhibitory effect of Varp through removing it from an endosome membrane, would switch the endosome to a state in which fusion with dense core lysosomes and endolysosomes would predominate and, thus, the luminal contents of the endosomes would be degraded (reviewed in refs. 47, 48) . Reduction in the levels of Varp on an endosomal membrane could be brought about by hydrolysis of GTP on Rab32 or Rab38 or binding Varp to a non-endosome localized protein.
In conclusion, the structural and biochemical studies described here demonstrate that, in vitro, Varp is a kinetic inhibitor of SNARE complex formations uniquely involving VAMP7. We predict that in vivo, Varp should sequentially inhibit but then, at the correct time, effectively promote the fusion of late endocytic organelles (where Varp is predominantly found) with target membranes. The switching from inhibiting to potentiating VAMP7-dependent fusion depends on the complement of other proteins that can bind directly or indirectly to Varp and/or the presence of SNAREs that can compete with VAMP7 for inclusion into SNARE complexes on the surface of an endosome. Varp could also function as a 'chaperone' , in the Victorian sense of the word, for VAMP7 in that it could inhibit 'improper' interactions that VAMP7 could indulge in, such as off-path VAMP7-mediated fusion events. That this is important for the cell is suggested by the observation that during its trafficking down the endocytic pathway from the plasma membrane mediated first by Hrb and then by AP3, VAMP7 is kept in an inactive state as part of cis-SNARE complexes. At the physiological level, the list of cellular processes in which Varp functions is probably not complete, as the previously published studies focused on specialized cell types. Nonetheless, in all the processes that have been characterized, the ability of Varp to bind VAMP7 is essential. The work presented here suggests that this is because of Varp's ability to regulate the participation of VAMP7 in membrane fusion events.
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We thank the beamline staff at IO3 (SLS Diamond plc), H. Kent Figure 8 Model of Varp function on an endosomal membrane. Through its simultaneous and direct binding to Rab32-GTP or Rab38-GTP (pink) and VAMP7 (purple and green), Varp will trap VAMP7 in an inactive form, allowing VAMP8 (turquoise) to outcompete VAMP7 for SNARE complex formation with syntaxin7, syntaxin8 and Vti1b. Hence, Varp could inhibit the amount of endosome-lysosome fusion and promote endosome-endosome fusion. This effect would be reversed when the GTP-bound Rab is converted to its GDP-bound form, which cannot bind Varp. The interaction between Varp and VAMP7 would then become effectively weaker, and the resulting free, uninhibited VAMP7 could then be used in the formation of SNARE complexes that would cause endosomelysosome fusion.
npg Quantification of the degree of immunolabeling was performed by counting gold particles overlying defined cellular components by scanning sections sequentially and recording images with a charge-coupled device camera (MegaView III). The labeling was repeated four times, and the distribution of 200 gold particles for each labeling experiment was determined.
